Climate change has degraded productivity of shelf sea food webs
Credit: Claire Widdicombe
A shortage of summer nutrients as a result of our changing climate has contributed to a 50% decline in important North East Atlantic plankton...
Graduate Aptitude Test in Biotechnology: Apply by June 18 – Mathrubhumi English
Applications have been invited for the Graduate Aptitude Test - Biotechnology (GAT-B), an examination to rank the participants for admission to the various DBT-supported PG programmes in participating institutions.
This examination was previously known as...
Boost For Inflammatory Disease Biotech NodThera With €49M Series B
The UK-US biotech NodThera has raised €48.7M in Series B funding to progress its drug candidate through clinical trials for the treatment of inflammatory conditions such as inflammatory bowel disease.
This round follows an impressive...
New discovery advances optical microscopy
Enables researchers to directly visualize unlabeled objects that have deep sub-wavelength separations
Credit: Lynford Goddard, Grainger Engineering
URBANA, Ill. – New Illinois ECE research is advancing the field...
Eclipse data illuminate mysteries of Sun’s corona
Credit: Solar Wind Sherpas
Researchers at the University of Hawai?i Institute for Astronomy (IfA) have been hard at work studying the solar corona, the outermost atmosphere of...
Impact of COVID-19 on the Life Science Industry
/* custom css */
.td_uid_1_5edb04838b318_rand { min-height: 0; }
jQuery(window).load(function () { jQuery('body').find('#td_uid_1_5edb04838b312 .td-element-style').each(function (index, element) { jQuery(element).css('opacity', 1); return; }); }); jQuery(window).ready(function () { // We need timeout because the...
Memo Therapeutics
Candidate: COVID-19 immunotherapy
Category: ANTIBODY
Type: SARS-CoV-2-specific virus-neutralizing antibody, to be selected.
Status: Memo said June 4 that it had identified “several” SARS-CoV-2-specific virus-neutralizing antibodies with the potential for development as a COVID-19 immunotherapy. The “ultra-rare” antibodies...
iBio – IBIO-201
Candidate: IBIO-201
Category: VAX
Type: Subunit vaccine combining antigens derived from the SARS-CoV-2 spike protein fused with the company’s patented lichenase booster molecule (LicKM), designed to enhance immune response.
Status: iBio said June 4 that it has...
Upsized Nasdaq IPO Yields Calliditas €80M to Commercialize Kidney Drug
Swedish company Calliditas Therapeutics has raised an €80M IPO on the Nasdaq Global Select Market — 20% above its initial target — to fund an ongoing phase III trial of its lead candidate treatment...
Researchers investigate new approaches to treating neurodegenerative diseases
Heidelberg researchers investigate new approaches to treating neurodegenerative diseases
Protecting nerve cells from losing their characteristic extensions, the dendrites, can reduce brain damage after a stroke. Neurobiologists from Heidelberg University have demonstrated this by means...
